• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤毛蛋白-1 靶向光动力诱导的组织因子释放引发血栓形成的早期阶段。

Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.

机构信息

Centre de Recherche en Automatique de Nancy (CRAN), Nancy-University, CNRS, Centre Alexis Vautrin, Avenue de Bourgogne, Brabois, 54511, Vandoeuvre-lès-Nancy, France.

出版信息

Pharm Res. 2010 Mar;27(3):468-79. doi: 10.1007/s11095-009-0035-8. Epub 2010 Jan 20.

DOI:10.1007/s11095-009-0035-8
PMID:20087632
Abstract

PURPOSE

This article characterizes the vascular effects following vascular-targeted photodynamic therapy with a photosensitizer which actively targets endothelial cells.

METHODS

This strategy was considered by coupling a chlorin to a heptapeptide targeting neuropilin-1 in human malignant glioma-bearing nude mice. A laser Doppler microvascular perfusion monitor was used to monitor microvascular blood perfusion in tumor tissue. Endothelial cells' ultra structural integrity was observed by transmission electron microscopy. The consequences of photosensitization on tumor vessels, tissue factor expression, fibrinogen consumption, and thrombogenic effects were studied by immunohistochemical staining.

RESULTS

Treatment of glioma-bearing mice with the conjugate showed a statistically significant tumor growth delay. Vascular effect was characterized by a decrease in tumor tissue blood flow at about 50% baseline during treatment not related to variations in temperature. This vascular shutdown was mediated by tumor blood vessels' congestion. A pro-thrombotic behavior of targeted endothelial cells in the absence of ultra structural changes led to the induction of tissue factor expression from the earliest times post-treatment. Expression of tissue factor-initiated thrombi formation was also related to an increase in fibrinogen consumption.

CONCLUSION

Using a peptide-conjugated photosensitizer targeting neuropilin-1, induction of tissue factor expression immediately post-treatment, led to the establishment of thrombogenic effects within the vessel lumen.

摘要

目的

本文描述了一种针对内皮细胞的血管靶向光动力疗法的血管效应。

方法

该策略是通过将叶绿素与靶向人恶性神经胶质瘤的神经纤毛蛋白-1的七肽偶联来实现的。使用激光多普勒微血管灌注监测仪监测肿瘤组织中的微血管血流灌注。通过透射电子显微镜观察内皮细胞的超微结构完整性。通过免疫组织化学染色研究光敏化对肿瘤血管、组织因子表达、纤维蛋白原消耗和血栓形成作用的影响。

结果

用缀合物治疗荷瘤小鼠可显著延缓肿瘤生长。血管效应的特征是在治疗过程中肿瘤组织血流下降约 50%,与温度变化无关。这种血管关闭是由肿瘤血管充血介导的。靶向内皮细胞的促血栓形成行为在没有超微结构变化的情况下导致组织因子表达的诱导,这发生在治疗后最早的时间。纤维蛋白原消耗的增加也与组织因子诱导的血栓形成有关。

结论

使用靶向神经纤毛蛋白-1的肽偶联光敏剂,在治疗后立即诱导组织因子表达,导致血管腔内血栓形成作用的建立。

相似文献

1
Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.神经纤毛蛋白-1 靶向光动力诱导的组织因子释放引发血栓形成的早期阶段。
Pharm Res. 2010 Mar;27(3):468-79. doi: 10.1007/s11095-009-0035-8. Epub 2010 Jan 20.
2
Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.靶向神经纤毛蛋白-1的肽缀合二氢卟吩型光敏剂的代谢谱:一项体内和体外研究。
Drug Metab Dispos. 2007 May;35(5):806-13. doi: 10.1124/dmd.106.013763. Epub 2007 Feb 5.
3
A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.一种与血管内皮生长因子165(VEGF165)竞争结合神经纤毛蛋白-1的肽介导二氢卟吩型光敏剂的靶向作用,并增强其在人内皮细胞中的光动力活性。
J Control Release. 2006 Mar 10;111(1-2):153-64. doi: 10.1016/j.jconrel.2005.11.017. Epub 2006 Jan 19.
4
Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.ATWLPPR偶联的靶向神经纤毛蛋白-1的二氢卟吩型光敏剂在荷瘤裸鼠体内的组织分布及药代动力学
Photochem Photobiol Sci. 2008 Apr;7(4):433-41. doi: 10.1039/b718259g. Epub 2008 Feb 14.
5
Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.肽偶联的二氢卟吩型光敏剂在体内外均能结合神经纤毛蛋白-1。
J Photochem Photobiol B. 2009 Aug 3;96(2):101-8. doi: 10.1016/j.jphotobiol.2009.04.008. Epub 2009 May 3.
6
Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.针对神经纤毛蛋白-1 的光动力疗法:具有改善稳定性的假肽的应用前景。
Biochem Pharmacol. 2010 Jul 15;80(2):226-35. doi: 10.1016/j.bcp.2010.03.036. Epub 2010 Apr 7.
7
New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.新型靶向神经纤毛蛋白-1的肽偶联二氢卟吩型光敏剂用于抗血管靶向光动力疗法
Int J Mol Sci. 2015 Oct 12;16(10):24059-80. doi: 10.3390/ijms161024059.
8
Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.血管靶向光致敏作用导致的肿瘤血管通透性:效应、机制及治疗意义
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):917-23. doi: 10.1158/1078-0432.CCR-05-1673.
9
Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.通过一种靶向因子 VII 的光动力疗法在体外和体内有效治疗耐药性乳腺癌。
Br J Cancer. 2011 Apr 26;104(9):1401-9. doi: 10.1038/bjc.2011.88. Epub 2011 Mar 22.
10
Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions.响应面法:优化体内光动力治疗条件的巨大潜力。
Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):244-52. doi: 10.1016/j.ijrobp.2009.04.004. Epub 2009 Jul 13.

引用本文的文献

1
Folic Acid and Leucovorin Have Potential to Prevent SARS-CoV-2-Virus Internalization by Interacting with S-Glycoprotein/Neuropilin-1 Receptor Complex.叶酸和甲酰四氢叶酸可能通过与 S-糖蛋白/神经纤毛蛋白-1 受体复合物相互作用来预防 SARS-CoV-2 病毒的内化。
Molecules. 2023 Mar 1;28(5):2294. doi: 10.3390/molecules28052294.
2
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke.神经纤毛蛋白1在新冠肺炎合并急性缺血性卒中患者中的作用
Biomedicines. 2022 Aug 20;10(8):2032. doi: 10.3390/biomedicines10082032.
3
Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.

本文引用的文献

1
Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions.响应面法:优化体内光动力治疗条件的巨大潜力。
Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):244-52. doi: 10.1016/j.ijrobp.2009.04.004. Epub 2009 Jul 13.
2
Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.肽偶联的二氢卟吩型光敏剂在体内外均能结合神经纤毛蛋白-1。
J Photochem Photobiol B. 2009 Aug 3;96(2):101-8. doi: 10.1016/j.jphotobiol.2009.04.008. Epub 2009 May 3.
3
Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer.
神经纤毛蛋白-1 在子痫前期、HIV-1 和 SARS-CoV-2 感染发病机制中的作用:综述。
Virus Res. 2022 Oct 2;319:198880. doi: 10.1016/j.virusres.2022.198880. Epub 2022 Jul 26.
4
Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR).表皮生长因子受体 (EGFR) 和血管内皮生长因子受体 (VEGFR) 的分子靶向治疗。
Molecules. 2021 Feb 18;26(4):1076. doi: 10.3390/molecules26041076.
5
Vascular targeted photodynamic therapy: A review of the efforts towards molecular targeting of tumor vasculature.血管靶向光动力疗法:肿瘤血管分子靶向治疗的研究进展综述
J Porphyr Phthalocyanines. 2019 Dec;23(11-12):1229-1240. doi: 10.1142/s1088424619300180.
6
The role of Neuropilin-1 in COVID-19.神经纤毛蛋白-1 在 COVID-19 中的作用。
PLoS Pathog. 2021 Jan 4;17(1):e1009153. doi: 10.1371/journal.ppat.1009153. eCollection 2021 Jan.
7
Multiscale Selectivity and in vivo Biodistribution of NRP-1Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma.NRP-1 靶向治疗性 AGuIX 纳米颗粒用于脑胶质瘤光动力治疗的多尺度选择性和体内生物分布。
Int J Nanomedicine. 2020 Nov 9;15:8739-8758. doi: 10.2147/IJN.S261352. eCollection 2020.
8
Functionalized Coat Protein Monomers and Oligomers as Nanocarriers for Anti-Cancer Peptides.功能化衣壳蛋白单体和寡聚体作为抗癌肽的纳米载体
Cancers (Basel). 2019 Oct 22;11(10):1609. doi: 10.3390/cancers11101609.
9
Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1.一种靶向神经纤毛蛋白-1的拟肽对髓母细胞瘤干细胞分化的刺激作用
Oncotarget. 2018 Feb 16;9(20):15312-15325. doi: 10.18632/oncotarget.24521. eCollection 2018 Mar 16.
10
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.用于胶质母细胞瘤血管靶向间质光动力治疗的超小AGuIX诊疗纳米颗粒。
Int J Nanomedicine. 2017 Sep 26;12:7075-7088. doi: 10.2147/IJN.S141559. eCollection 2017.
用于表征乳腺癌中人酪氨酸激酶受体下游信号传导的磷酸化蛋白阵列分析方法的验证
Clin Chem. 2009 Jul;55(7):1327-36. doi: 10.1373/clinchem.2008.116632. Epub 2009 May 14.
4
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.用强效肿瘤血管生成抑制剂进行短期治疗后转移加速。
Cancer Cell. 2009 Mar 3;15(3):232-9. doi: 10.1016/j.ccr.2009.01.021.
5
The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid improves the antitumor efficacy and shortens treatment time associated with Photochlor-sensitized photodynamic therapy in vivo.血管破坏剂5,6-二甲基呫吨酮-4-乙酸可提高体内与光氯致敏光动力疗法相关的抗肿瘤疗效并缩短治疗时间。
Photochem Photobiol. 2009 Jan-Feb;85(1):50-6. doi: 10.1111/j.1751-1097.2008.00395.x. Epub 2008 Jul 17.
6
Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.ATWLPPR偶联的靶向神经纤毛蛋白-1的二氢卟吩型光敏剂在荷瘤裸鼠体内的组织分布及药代动力学
Photochem Photobiol Sci. 2008 Apr;7(4):433-41. doi: 10.1039/b718259g. Epub 2008 Feb 14.
7
Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.抗血管生成ATWLPPR肽抑制VEGF(165)与神经纤毛蛋白-1结合的结构-功能分析及ATWLPPR/神经纤毛蛋白-1复合物的分子动力学模拟
Peptides. 2007 Dec;28(12):2397-402. doi: 10.1016/j.peptides.2007.09.013. Epub 2007 Sep 29.
8
Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.靶向神经纤毛蛋白-1的肽缀合二氢卟吩型光敏剂的代谢谱:一项体内和体外研究。
Drug Metab Dispos. 2007 May;35(5):806-13. doi: 10.1124/dmd.106.013763. Epub 2007 Feb 5.
9
Vascular and cellular targeting for photodynamic therapy.光动力疗法的血管和细胞靶向作用
Crit Rev Eukaryot Gene Expr. 2006;16(4):279-305. doi: 10.1615/critreveukargeneexpr.v16.i4.10.
10
Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.血管靶向光致敏作用导致的肿瘤血管通透性:效应、机制及治疗意义
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):917-23. doi: 10.1158/1078-0432.CCR-05-1673.